These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 4662684

  • 1. [Drug prevention of hyperbilirubinemia in newborn infants. 5. Cumulative effect of the combination of the inductors phenobarbital and nikethamide].
    Gmyrek D, Weh L, Kalz M, Bunke H, Cario WR, Lindenau E, Neumann R, Pietsch I, Scigalla P, Sima K, Syllm-Rapoport I.
    Dtsch Gesundheitsw; 1972 Nov 23; 27(47):2221-7. PubMed ID: 4662684
    [No Abstract] [Full Text] [Related]

  • 2. [Prevention of toxic hyperbilirubinemia in premature and mature newborn infants by use of an enzyme-inducing combination: phenobarbital-nikethamide].
    Kintzel HW.
    Helv Paediatr Acta; 1973 Nov 23; 30():Suppl:35-7. PubMed ID: 4711239
    [No Abstract] [Full Text] [Related]

  • 3. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
    Kintzel HW, Schwarze R, Hinkel GK.
    Schweiz Med Wochenschr; 1972 Sep 23; 102(38):1339-45. PubMed ID: 4630163
    [No Abstract] [Full Text] [Related]

  • 4. [Prevention of hyperbilirubinemia in premature infants using a combination of two enzyme inductors: phenobarbitol and nikethamide].
    Hinkel GK, Kintzel HW, Schwarze R, Händel A.
    Dtsch Gesundheitsw; 1972 Sep 28; 27(39):1854-7. PubMed ID: 4634399
    [No Abstract] [Full Text] [Related]

  • 5. [Synergistic effect of combined enzyme inductors (Phenobarbital and Nikethamide) on the bilirubin concentration in the serum of newborn infants].
    Kintzel HW, Schwarze R, Hinkel GK.
    Dtsch Gesundheitsw; 1971 Dec 16; 26(51):2424-8. PubMed ID: 5148595
    [No Abstract] [Full Text] [Related]

  • 6. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
    Gmyrek D, Bunke H, Cario WR, Daberkow H, Läuter J, Saworra H, Weh L, Syllm-Rapoport I.
    Kinderarztl Prax; 1973 Apr 16; 41(4):174-90. PubMed ID: 4731678
    [No Abstract] [Full Text] [Related]

  • 7. [Prevention of neonatal hyperbilirubinemia by enzyme inducers. Effectiveness of a phenobarbital-nikethamide association].
    Patriarca PL, Peracino A, Marcovina S, Zecca G.
    Minerva Pediatr; 1975 Apr 21; 27(14):865-73. PubMed ID: 1134450
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical experiences using phenobarbital in the prevention of hyperbilirubinemia in mature newborn infants in a controlled study].
    Schambach K, Menzel K.
    Z Arztl Fortbild (Jena); 1975 May 15; 69(10):535-7. PubMed ID: 1199187
    [No Abstract] [Full Text] [Related]

  • 9. Therapy in congenital hyperbilirubinemia: phenobarbital and diethylnicotinamide.
    Ertel IJ, Newton WA.
    Pediatrics; 1969 Jul 15; 44(1):43-8. PubMed ID: 5795402
    [No Abstract] [Full Text] [Related]

  • 10. [Preventive drug therapy of hyperbilirubinemia in full-term infants].
    Langer P, Berg G, Endig W.
    Kinderarztl Prax; 1977 Jan 15; 45(1):11-4. PubMed ID: 556483
    [No Abstract] [Full Text] [Related]

  • 11. [Enzyme inductors in the treatment of neonatal hyperbilirubinemia].
    Daskalova E.
    Akush Ginekol (Sofiia); 1977 Jan 15; 16(3):213-9. PubMed ID: 331988
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy of fetal Rh-erythroblastosis using the enzyme inductor combination of phenobarbital-nicethamide].
    Kintzel HW, Hinkel GK, Schwarze R, Händel A, Böttger D.
    Dtsch Gesundheitsw; 1972 Jul 27; 27(30):1405-8. PubMed ID: 4673197
    [No Abstract] [Full Text] [Related]

  • 13. [Drug therapy in the prevention of transitory hyperbilirubinemia in premature newborn infants].
    Reineke J.
    ZFA (Stuttgart); 1976 May 10; 52(13):681-2. PubMed ID: 1274416
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of various drugs on serum bilirubin level in newborn infants].
    Händel A, Hinkel GK, Kintzel HW, Schwarze R.
    Padiatr Padol; 1973 May 10; 8(3):307-15. PubMed ID: 4715041
    [No Abstract] [Full Text] [Related]

  • 15. An enzyme inductor combination for the prevention of hyperbilirubinemia in premature infants.
    Hinkel GK, Kintzel HW, Schwarze R, Händel A.
    Acta Paediatr Scand; 1974 May 10; 63(3):393-7. PubMed ID: 4838967
    [No Abstract] [Full Text] [Related]

  • 16. [Prevention by use of drugs of hyperbilirubinemia in the newborn. VI. Animal experiments and clinical tests of Vasalgin].
    Lindenau E, Cario WR, Grübner I, Juras H, Kalz M, Klinger W, Liersch S, Meyer C, Splinter K, Weh L, Gmyrek D.
    Padiatr Grenzgeb; 1972 May 10; 11(5):369-79. PubMed ID: 4667525
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of hyperbilirubinemia in premature and newborn infants using orotic acid].
    Hinkel GK, Kintzel HW, Schwarze R.
    Dtsch Gesundheitsw; 1972 Dec 21; 27(51):2414-9. PubMed ID: 4650692
    [No Abstract] [Full Text] [Related]

  • 18. [Prevention of morbus haemolyticus neonatorum and of transitory hyperbilirubinemias of newborn infants through an enzyme inductor combination].
    Kintzel HW.
    Blut; 1973 May 21; 26(5):297-302. PubMed ID: 4196748
    [No Abstract] [Full Text] [Related]

  • 19. [The influence of a short-time enzyme induction with phenobarbital on hyperbilirubinemia in premature newborns].
    Zwacka G, Frenzel J.
    Dtsch Gesundheitsw; 1970 Nov 19; 25(47):2230-4. PubMed ID: 5487509
    [No Abstract] [Full Text] [Related]

  • 20. [Practical procedure in the prophylaxis and therapy of hyperbilirubinemia in the newborn infant].
    Kunze W, Joppien HG.
    Z Arztl Fortbild (Jena); 1981 Feb 01; 75(3):108-10. PubMed ID: 7281734
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.